US Stock MarketDetailed Quotes

Spyre Therapeutics (SYRE)

Watchlist
  • 71.900
  • +2.230+3.20%
Close Apr 27 16:00 ET
  • 71.500
  • -0.400-0.56%
Post 20:01 ET
6.20BMarket Cap-36.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spyre Therapeutics (SYRE) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
25.44%756.53M
25.44%756.53M
17.37%486.2M
23.61%526.58M
16.54%564.82M
77.76%603.09M
77.76%603.09M
103.45%414.23M
81.00%426M
1,159.53%484.64M
-Cash and cash equivalents
-4.14%85.72M
-4.14%85.72M
-9.34%64.9M
80.89%81.66M
-78.69%48.49M
-52.66%89.42M
-52.66%89.42M
-20.99%71.58M
-80.82%45.14M
545.67%227.55M
-Short-term investments
30.59%670.81M
30.59%670.81M
22.95%421.3M
16.82%444.92M
100.84%516.33M
241.57%513.67M
241.57%513.67M
203.21%342.65M
--380.85M
7,847.11%257.09M
Other current assets
294.50%21.25M
294.50%21.25M
168.62%18.41M
25.78%12.25M
87.99%4.95M
139.27%5.39M
139.27%5.39M
213.31%6.85M
237.99%9.74M
-52.72%2.63M
Total current assets
27.82%777.78M
27.82%777.78M
19.84%504.6M
23.66%538.83M
16.93%569.77M
78.16%608.47M
78.16%608.47M
104.46%421.08M
81.64%435.74M
998.08%487.27M
Non current assets
Other non current assets
----
----
----
----
-96.96%10K
-96.98%10K
-96.98%10K
-99.24%10K
-75.06%331K
-76.30%329K
Total non current assets
--0
--0
--0
--0
-96.96%10K
-96.98%10K
-96.98%10K
-99.24%10K
-90.91%331K
-95.93%329K
Total assets
27.82%777.78M
27.82%777.78M
19.83%504.6M
23.57%538.83M
16.85%569.78M
77.99%608.48M
77.99%608.48M
103.16%421.09M
79.06%436.07M
829.60%487.6M
Liabilities
Current liabilities
Payables
602.76%8.92M
602.76%8.92M
-41.84%11.43M
-72.87%3.74M
-66.53%6.24M
-92.74%1.27M
-92.74%1.27M
-8.63%19.65M
-41.69%13.8M
803.69%18.63M
-accounts payable
1,236.94%8.9M
1,236.94%8.9M
44.38%7.46M
14.89%3.71M
18.77%3.69M
-25.67%666K
-25.67%666K
207.81%5.17M
13.21%3.23M
50.63%3.11M
-Due to related parties current
-97.68%14K
-97.68%14K
-72.58%3.97M
-99.71%31K
-83.59%2.55M
-96.36%603K
-96.36%603K
-26.95%14.48M
-49.22%10.57M
--15.53M
Current accrued expenses
-12.52%18.83M
-12.52%18.83M
101.64%18.53M
426.17%15.89M
3.20%19.7M
151.25%21.52M
151.25%21.52M
-12.45%9.19M
-85.75%3.02M
192.36%19.09M
Other current liabilities
-10.09%23M
-10.09%23M
-54.77%11.19M
2,178.11%60.14M
1,567.22%43.18M
1,262.14%25.58M
1,262.14%25.58M
229.43%24.74M
-98.49%2.64M
828.32%2.59M
Current liabilities
8.56%58.69M
8.56%58.69M
-19.58%46.27M
275.46%83.06M
65.07%70.68M
69.05%54.06M
69.05%54.06M
28.23%57.54M
-90.47%22.12M
238.83%42.82M
Non current liabilities
Preferred securities outside stock equity
----
----
----
----
----
--0
--0
--0
--0
--253.41M
Other non current liabilities
-89.46%3.86M
-89.46%3.86M
-91.07%3.23M
----
-57.84%16.49M
-11.35%36.62M
-11.35%36.62M
74.77%36.16M
108.21%39.56M
--39.11M
Total non current liabilities
-89.46%3.86M
-89.46%3.86M
-91.07%3.23M
--0
-94.36%16.49M
-70.91%36.62M
-70.91%36.62M
-91.13%36.16M
-81.91%39.56M
4,645.54%292.52M
Total liabilities
-31.03%62.55M
-31.03%62.55M
-47.17%49.5M
34.66%83.06M
-74.01%87.17M
-42.55%90.68M
-42.55%90.68M
-79.30%93.7M
-86.32%61.68M
1,683.59%335.33M
Shareholders'equity
Share capital
0.00%155.84M
0.00%155.84M
0.00%155.83M
0.00%155.83M
-15.74%155.83M
-15.74%155.83M
-15.74%155.83M
2,226,071.43%155.83M
2,597,100.00%155.83M
3,082,183.33%184.94M
-common stock
15.38%15K
15.38%15K
8.33%13K
8.33%13K
30.00%13K
30.00%13K
30.00%13K
71.43%12K
100.00%12K
66.67%10K
-Preferred stock
0.00%155.82M
0.00%155.82M
0.00%155.82M
0.00%155.82M
-15.74%155.82M
-15.74%155.82M
-15.74%155.82M
--155.82M
--155.82M
--184.93M
Retained earnings
-15.96%-1.13B
-15.96%-1.13B
-16.26%-1.07B
-24.41%-1.05B
-25.85%-1.02B
-27.21%-972.43M
-27.21%-972.43M
-30.65%-916.14M
-28.13%-847.11M
-82.02%-808.27M
Paid-in capital
26.38%1.69B
26.38%1.69B
25.53%1.36B
26.94%1.35B
73.11%1.34B
74.82%1.33B
74.82%1.33B
138.23%1.09B
134.98%1.07B
62.44%775.97M
Gains losses not affecting retained earnings
382.78%869K
382.78%869K
-45.71%791K
182.10%454K
287.88%682K
-40.40%180K
-40.40%180K
1,203.79%1.46M
-5,127.27%-553K
-5,950.00%-363K
Total stockholders'equity
38.13%715.24M
38.13%715.24M
39.01%455.1M
21.74%455.77M
216.95%482.61M
181.39%517.8M
181.39%517.8M
233.41%327.39M
280.54%374.39M
352.48%152.27M
Total equity
38.13%715.24M
38.13%715.24M
39.01%455.1M
21.74%455.77M
216.95%482.61M
181.39%517.8M
181.39%517.8M
233.41%327.39M
280.54%374.39M
352.48%152.27M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 25.44%756.53M25.44%756.53M17.37%486.2M23.61%526.58M16.54%564.82M77.76%603.09M77.76%603.09M103.45%414.23M81.00%426M1,159.53%484.64M
-Cash and cash equivalents -4.14%85.72M-4.14%85.72M-9.34%64.9M80.89%81.66M-78.69%48.49M-52.66%89.42M-52.66%89.42M-20.99%71.58M-80.82%45.14M545.67%227.55M
-Short-term investments 30.59%670.81M30.59%670.81M22.95%421.3M16.82%444.92M100.84%516.33M241.57%513.67M241.57%513.67M203.21%342.65M--380.85M7,847.11%257.09M
Other current assets 294.50%21.25M294.50%21.25M168.62%18.41M25.78%12.25M87.99%4.95M139.27%5.39M139.27%5.39M213.31%6.85M237.99%9.74M-52.72%2.63M
Total current assets 27.82%777.78M27.82%777.78M19.84%504.6M23.66%538.83M16.93%569.77M78.16%608.47M78.16%608.47M104.46%421.08M81.64%435.74M998.08%487.27M
Non current assets
Other non current assets -----------------96.96%10K-96.98%10K-96.98%10K-99.24%10K-75.06%331K-76.30%329K
Total non current assets --0--0--0--0-96.96%10K-96.98%10K-96.98%10K-99.24%10K-90.91%331K-95.93%329K
Total assets 27.82%777.78M27.82%777.78M19.83%504.6M23.57%538.83M16.85%569.78M77.99%608.48M77.99%608.48M103.16%421.09M79.06%436.07M829.60%487.6M
Liabilities
Current liabilities
Payables 602.76%8.92M602.76%8.92M-41.84%11.43M-72.87%3.74M-66.53%6.24M-92.74%1.27M-92.74%1.27M-8.63%19.65M-41.69%13.8M803.69%18.63M
-accounts payable 1,236.94%8.9M1,236.94%8.9M44.38%7.46M14.89%3.71M18.77%3.69M-25.67%666K-25.67%666K207.81%5.17M13.21%3.23M50.63%3.11M
-Due to related parties current -97.68%14K-97.68%14K-72.58%3.97M-99.71%31K-83.59%2.55M-96.36%603K-96.36%603K-26.95%14.48M-49.22%10.57M--15.53M
Current accrued expenses -12.52%18.83M-12.52%18.83M101.64%18.53M426.17%15.89M3.20%19.7M151.25%21.52M151.25%21.52M-12.45%9.19M-85.75%3.02M192.36%19.09M
Other current liabilities -10.09%23M-10.09%23M-54.77%11.19M2,178.11%60.14M1,567.22%43.18M1,262.14%25.58M1,262.14%25.58M229.43%24.74M-98.49%2.64M828.32%2.59M
Current liabilities 8.56%58.69M8.56%58.69M-19.58%46.27M275.46%83.06M65.07%70.68M69.05%54.06M69.05%54.06M28.23%57.54M-90.47%22.12M238.83%42.82M
Non current liabilities
Preferred securities outside stock equity ----------------------0--0--0--0--253.41M
Other non current liabilities -89.46%3.86M-89.46%3.86M-91.07%3.23M-----57.84%16.49M-11.35%36.62M-11.35%36.62M74.77%36.16M108.21%39.56M--39.11M
Total non current liabilities -89.46%3.86M-89.46%3.86M-91.07%3.23M--0-94.36%16.49M-70.91%36.62M-70.91%36.62M-91.13%36.16M-81.91%39.56M4,645.54%292.52M
Total liabilities -31.03%62.55M-31.03%62.55M-47.17%49.5M34.66%83.06M-74.01%87.17M-42.55%90.68M-42.55%90.68M-79.30%93.7M-86.32%61.68M1,683.59%335.33M
Shareholders'equity
Share capital 0.00%155.84M0.00%155.84M0.00%155.83M0.00%155.83M-15.74%155.83M-15.74%155.83M-15.74%155.83M2,226,071.43%155.83M2,597,100.00%155.83M3,082,183.33%184.94M
-common stock 15.38%15K15.38%15K8.33%13K8.33%13K30.00%13K30.00%13K30.00%13K71.43%12K100.00%12K66.67%10K
-Preferred stock 0.00%155.82M0.00%155.82M0.00%155.82M0.00%155.82M-15.74%155.82M-15.74%155.82M-15.74%155.82M--155.82M--155.82M--184.93M
Retained earnings -15.96%-1.13B-15.96%-1.13B-16.26%-1.07B-24.41%-1.05B-25.85%-1.02B-27.21%-972.43M-27.21%-972.43M-30.65%-916.14M-28.13%-847.11M-82.02%-808.27M
Paid-in capital 26.38%1.69B26.38%1.69B25.53%1.36B26.94%1.35B73.11%1.34B74.82%1.33B74.82%1.33B138.23%1.09B134.98%1.07B62.44%775.97M
Gains losses not affecting retained earnings 382.78%869K382.78%869K-45.71%791K182.10%454K287.88%682K-40.40%180K-40.40%180K1,203.79%1.46M-5,127.27%-553K-5,950.00%-363K
Total stockholders'equity 38.13%715.24M38.13%715.24M39.01%455.1M21.74%455.77M216.95%482.61M181.39%517.8M181.39%517.8M233.41%327.39M280.54%374.39M352.48%152.27M
Total equity 38.13%715.24M38.13%715.24M39.01%455.1M21.74%455.77M216.95%482.61M181.39%517.8M181.39%517.8M233.41%327.39M280.54%374.39M352.48%152.27M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.72%
Sample Name
Sample Code
 +8.47%
Sample Name
Sample Code
 +7.98%
4
VanEck Oil Services ETF
OIH
+5.58%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.68%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.58%
Sample Name
Sample Code
 +6.89%
Sample Name
Sample Code
 +5.36%
4
Chagee Holdings
CHA
+3.18%
5
Qifu Technology
QFIN
+0.60%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -